Tonix Pharmaceuticals Holding Corp. (TNXP)
USD 0.36
(9.25%)
USD 0.36
(9.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -102 Million | -98.05 Million | -75.55 Million | -48.56 Million | -26.68 Million | -23.97 Million |
| Net Income | -116.65 Million | -110.21 Million | -92.28 Million | -50.46 Million | -28.61 Million | -26.08 Million |
| Depreciation & Amortization | 4.29 Million | 1.25 Million | 50 Thousand | 27 Thousand | 26 Thousand | 54 Thousand |
| Deferred income taxes | 3.42 Million | -14.46 Million | - | - | 154 Thousand | - |
| Stock-based compensation | 9.27 Million | 10.91 Million | 7.89 Million | 2.87 Million | 1.45 Million | 1.62 Million |
| Change in working capital | -35 Thousand | -2000.00 | 5.78 Million | -2.36 Million | 452 Thousand | 437 Thousand |
| Other non-cash items | -2.3 Million | 14.46 Million | 3 Million | 1.36 Million | -154 Thousand | 1.62 Million |
| Investing Cash Flow | -29.07 Million | -48.14 Million | -35.3 Million | -8.56 Million | -17 Thousand | -6000.00 |
| Investments in PPE | -7.89 Million | -48.14 Million | -35.3 Million | -8.56 Million | -17 Thousand | -6000.00 |
| Acquisitions | -21.17 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 999 Thousand | - | - | - | -17 Thousand | -6000.00 |
| Financing Cash Flow | 36.51 Million | 87.84 Million | 212.48 Million | 123.1 Million | 12.91 Million | 23.53 Million |
| Debt repayment | -8.94 Million | - | - | - | - | - |
| Dividends payments | - | -6.65 Million | - | -451 Thousand | -2.47 Million | -3.26 Million |
| Common Stock Repurchased | -13.96 Million | -47.25 Million | 3 Million | 1.36 Million | - | - |
| Common Stock Issuance | 50.48 Million | 94.46 Million | 212.48 Million | 123.1 Million | 5.86 Million | 12.71 Million |
| Other Financing Activities | 22.57 Million | 47.29 Million | 212.48 Million | 123.1 Million | 9.52 Million | 14.09 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.49 Million | -1.04 Million | 3.52 Million | 1.52 Million | 1.66 Million | 106 Thousand |
| Inventory | 61 Thousand | - | - | - | - | - |
| Other working capital | 3.39 Million | 1.04 Million | 2.25 Million | -3.89 Million | -1.21 Million | 331 Thousand |
| Cash at beginning of period | 120.22 Million | 178.9 Million | 77.3 Million | 11.34 Million | 25.13 Million | 25.58 Million |
| Cash at end of period | 24.94 Million | 120.47 Million | 178.9 Million | 77.3 Million | 11.34 Million | 25.13 Million |
| Capital Expenditure | -7.89 Million | -48.14 Million | -35.3 Million | -8.56 Million | -17 Thousand | -6000.00 |
| Effect of forex changes on cash | -65 Thousand | -74 Thousand | -31 Thousand | -16 Thousand | -4000.00 | -13 Thousand |
| Net cash flow / Change in cash | -95.28 Million | -58.43 Million | 101.59 Million | 65.95 Million | -13.78 Million | -451 Thousand |
| Free Cash Flow | -109.89 Million | -146.2 Million | -110.86 Million | -57.13 Million | -26.7 Million | -23.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -78.77 Million | -14.93 Million | -116.65 Million | -27.32 Million | -27.97 Million | -28.35 Million |
| Depreciation & Amortization | 1.2 Million | 1.21 Million | 4.29 Million | 1.49 Million | 1.21 Million | 921 Thousand |
| Deferred income taxes | - | - | 3.42 Million | -9.01 Million | - | -4.54 Million |
| Stock-based compensation | 1.15 Million | 1.69 Million | 9.27 Million | 2.03 Million | 2.07 Million | 2.36 Million |
| Change in working capital | 4.72 Million | 1.16 Million | -35 Thousand | 372.37 Thousand | 1.49 Million | 1.7 Million |
| Other non-cash items | 61.05 Million | -6.85 Million | -2.3 Million | 10.74 Million | -196 Thousand | 4.54 Million |
| Investing Cash Flow | 1771.13 | -108 Thousand | -29.07 Million | -98.6 Thousand | -821 Thousand | -24.01 Million |
| Investments in PPE | 1771.13 | -108 Thousand | -7.89 Million | -355.64 Thousand | -1.81 Million | -1.84 Million |
| Acquisitions | - | - | -21.17 Million | 257.04 Thousand | 794.02 Thousand | -22.49 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 999 Thousand | 7000.00 | 197.97 Thousand | 324.95 Thousand |
| Financing Cash Flow | 6.91 Million | -212 Thousand | 36.51 Million | 41.28 Million | 6.27 Million | 1.02 Million |
| Debt repayment | -689.58 Thousand | -235 Thousand | -8.94 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -13.96 Million | 164.79 Thousand | -140.1 Thousand | -204.65 Thousand |
| Common Stock Issuance | 10.55 Million | 23 Thousand | 50.48 Million | 41.12 Million | 6.27 Million | 1.02 Million |
| Other Financing Activities | -2.95 Million | -212 Thousand | 22.57 Million | 40.71 Million | 140.1 Thousand | 204.65 Thousand |
| Accounts receivables | -3.33 Million | - | - | -61 Thousand | -1.56 Million | - |
| Accounts payables | 3.61 Million | 2.97 Million | -3.49 Million | -3.99 Million | 1.01 Million | -1.14 Million |
| Inventory | 1.11 Million | 1.28 Million | 61 Thousand | 61 Thousand | - | - |
| Other working capital | 3.27 Million | -3.09 Million | 3.39 Million | 4.36 Million | 474 Thousand | 2.85 Million |
| Cash at beginning of period | 7.04 Million | 24.94 Million | 120.22 Million | 6.91 Million | 25.86 Million | 72.21 Million |
| Cash at end of period | 4.15 Million | 7.04 Million | 24.94 Million | 24.94 Million | 7.91 Million | 25.86 Million |
| Capital Expenditure | 1771.13 | -108 Thousand | -7.89 Million | -355.64 Thousand | -1.81 Million | -1.84 Million |
| Effect of forex changes on cash | 1000.00 | -4000.00 | -65 Thousand | -10 Thousand | -12 Thousand | - |
| Net cash flow / Change in cash | -2.89 Million | -17.89 Million | -95.28 Million | 18.03 Million | -17.94 Million | -46.35 Million |
| Free Cash Flow | -9.46 Million | -17.68 Million | -109.89 Million | -22.04 Million | -25.19 Million | -25.21 Million |
GNENF
AGDXF
PEB
BANKBARODA
DCO
2338